Randomised controlled trials in cardiovascular medicine: past achievements, future challenges

This publication has 27 references indexed in Scilit:

• "A calculated risk": the Salk polio vaccine field trials of 1954
  BMJ, 1998
• Selection of patients for randomized controlled trials: Implications of wide or narrow eligibility criteria
  Statistics in Medicine, 1990
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989
• Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
  1988
• Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI).
  1987
• Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
  1986
• Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials
  European Heart Journal, 1985
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985
• Why do we need some large, simple randomized trials?
  Statistics in Medicine, 1984
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design
  British Journal of Cancer, 1976